Emergent Biosolutions, Inc.
EBS
F
|
$1.94
-2.02%
510K
|
Health Technology
(0.0% 1d) (-19.8% 1m) (-83.1% 1y) (0.0% 2d) (0.0% 3d) (-11.2% 7d) (23.77% volume)
Earnings Calendar: 2024-02-27
Market Cap: $ 101,638,082
http://www.emergentbiosolutions.com
Sec Filling | Patents | 1834 employees
(US) Emergent BioSolutions Inc. engages in the development, manufacture, and commercialization of medical countermeasures. It offers specialty products for civilian and military populations that address accidental, intentional and naturally occurring public health threats. The firm's products include ACAM2000, BioThrax, Raxibacuma, Vaxchora, and VIGIV. Its business units include Vaccines and Anti-Infectives; Antibody Therapeutics; Devices; and Contract Development and Manufacturing. The company was founded by Fuad El-Hibri in May 1998 and is headquartered in Gaithersburg, MD.
vaccine antibody military monkeypox smallpox tembexa injection
add to watch list Paper trade email alert is off
Press-releases
Aquestive Therapeutics Strengthens Board of Directors with Experienced Biotech Executive
Published: 2024-04-01 (Crawled : 12:00) - globenewswire.com
EBS F | $1.94 -2.02% 510K
|
Health Technology
|
| O: -4.85%
H: 2.18%
C: -9.8%
AQST | $3.77 -4.32% 1.3M
|
Health Technology
|
| O: -3.85%
H: 2.35%
C: -2.82%
biotech therapeutics
Emergent BioSolutions Continues to Broaden Access, Awareness and Availability of NARCAN® Nasal Spray to Help Save Lives from the Ongoing Opioid Crisis
Published: 2024-03-28 (Crawled : 12:00) - globenewswire.com
EBS F | $1.94 -2.02% 510K
|
Health Technology
|
| O: 3.47%
H: 0.0%
C: 0.0%
narcan opioid save ongoing spray
Emergent BioSolutions Receives NAI Status for Baltimore Bayview Manufacturing Facility
Published: 2024-03-25 (Crawled : 12:00) - globenewswire.com
EBS F | $1.94 -2.02% 510K
|
Health Technology
|
| O: 0.83%
H: 8.44%
C: 4.53%
Emergent BioSolutions Reports Fourth Quarter 2023 Financial Results
Published: 2024-03-06 (Crawled : 22:00) - globenewswire.com
EBS F | $1.94 -2.02% 510K
|
Health Technology
|
| O: -16.26%
H: 6.59%
C: 1.47%
financial results
Emergent BioSolutions to Release Fourth Quarter & Full Year 2023 Financial Results, and Conduct Conference Call on March 6, 2024
Published: 2024-02-29 (Crawled : 12:00) - globenewswire.com
EBS F | $1.94 -2.02% 510K
|
Health Technology
|
| O: 3.75%
H: 1.99%
C: -2.71%
conference year financial
Emergent BioSolutions Appoints Industry Leader Joseph C. Papa as New President and CEO
Published: 2024-02-21 (Crawled : 12:00) - globenewswire.com
EBS F | $1.94 -2.02% 510K
|
Health Technology
|
| O: 11.84%
H: 91.18%
C: 59.41%
ceo
Emergent BioSolutions Awarded Procurement Contract Valued up to $235.8 Million to Supply BioThrax® (Anthrax Vaccine Adsorbed) to the U.S. Department of Defense
Published: 2024-01-11 (Crawled : 13:00) - globenewswire.com
EBS F | $1.94 -2.02% 510K
|
Health Technology
|
| O: 3.69%
H: 0.0%
C: -6.67%
biothrax defense vaccine contract million
Emergent BioSolutions to Present at the 42nd Annual J.P. Morgan Healthcare Conference on January 11, 2024
Published: 2024-01-09 (Crawled : 12:30) - globenewswire.com
EBS F | $1.94 -2.02% 510K
|
Health Technology
|
| O: -0.93%
H: 0.0%
C: -2.8%
conference
Emergent BioSolutions Receives $75 Million Contract Option from BARDA to Procure Doses of CYFENDUS™ (Anthrax Vaccine Adsorbed, Adjuvanted)
Published: 2023-11-28 (Crawled : 12:00) - globenewswire.com
EBS F | $1.94 -2.02% 510K
|
Health Technology
|
| O: 2.42%
H: 1.42%
C: -5.19%
vaccine contract
Emergent BioSolutions Receives NYSE Notice Regarding Delayed Form 10-Q Filing
Published: 2023-11-24 (Crawled : 12:30) - globenewswire.com
EBS F | $1.94 -2.02% 510K
|
Health Technology
|
| O: -4.31%
H: 9.0%
C: 4.5%
Last 15 days Sec forms
Your Today's Watch List
Sign in to create a watchlistGainers vs Losers
| 54% | 46% |
Top 10 Gainers
WISA 4 | $7.86 349.14% 120M
|
Electronic Technology
TPET | $0.4951 114.24% 29M
|
n/a
JAGX | $0.1771 49.07% 540M
|
Health Technology
SXTC | $2.03 45.0% 27M
|
Health Technology
SPCB | $0.3888 40.87% 27M
|
Electronic Technology
DYNT | $0.52 40.39% 20M
|
Health Technology
SNGX | $0.54 39.86% 7.3M
|
Health Technology
BSGM | $1.53 39.09% 2.6M
|
Health Technology
MCBC | $13.74 38.37% 1.6M
|
Finance
PALI | $5.51 32.45% 28M
|
Manufacturing
Last 48 Hours Insiders Buying
RVP P 3587 | $1.06 -1.85% 21K
|
Health Technology
|
17:00
TPL P 12 | $588.26 0.75% 12K
|
Miscellaneous
|
16:01
HNRA | $2.617 10.89% 260K
|
n/a
|
15:02
TGEN | $0.67 16K
|
Utilities
|
14:30
RMCF | $3.6492 9.1K
|
Consumer Non-Durables
|
20:10